The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Metabolic Profiling of CSF: Evidence That Early Intervention May Impact on Disease Progression and Outcome in Schizophrenia
Open accessAbstract
BACKGROUND: The identification of schizophrenia biomarkers is a crucial step towards improving current diagnosis, developing new presymptomatic treatments, identifying high-risk individuals and disease subgroups, and assessing the efficacy of preventative interventions at a rate that is not currently possible. METHODS AND FINDINGS: (1)H nuclear magnetic resonance spectroscopy in conjunction with computerized pattern recognition analysis were employed to investigate metabolic profiles of a total of 152 cerebrospinal fluid (CSF) samples from drug-naïve or minimally treated patients with first-onset paranoid schizophrenia (referred to as "schizophrenia" in the following text) and healthy controls. Partial least square discriminant analysis showed a highly significant separation of patients with first-onset schizophrenia away from healthy controls. Short-term treatment with antipsychotic medication resulted in a normalization of the disease signature in over half the patients, well before overt clinical improvement. No normalization was observed in patients in which treatment had not been initiated at first presentation, providing the first molecular evidence for the importance of early intervention for psychotic disorders. Furthermore, the alterations identified in drug-naïve patients could be validated in a test sample set achieving a sensitivity and specificity of 82% and 85%, respectively. CONCLUSIONS: Our findings suggest brain-specific alterations in glucoregulatory processes in the CSF of drug-naïve patients with first-onset schizophrenia, implying that these abnormalities are intrinsic to the disease, rather than a side effect of antipsychotic medication. Short-term treatment with atypical antipsychotic medication resulted in a normalization of the CSF disease signature in half the patients well before a clinical improvement would be expected. Furthermore, our results suggest that the initiation of antipsychotic treatment during a first psychotic episode may influence treatment response and/or outcome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nicholson, J. K., Lindon, J. C., & Holmes, E. (1999) · Xenobiotica · doi:10.1080/004982599238047 · Cited by 3,895
Self-citationMetabonomics: a platform for studying drug toxicity and gene function
Nicholson, J. K., Connelly, J., Lindon, J. C., & Holmes, E. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd728 · Cited by 1,914
Self-citationHakak, Y., Walker, J. R., Li, C., Wong, W. H., Davis, K. L., Buxbaum, J. D., Haroutunian, V., & Fienberg, A. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081071198 · Cited by 1,192
Orthogonal signal correction of near-infrared spectra
Wold, S., Antti, H., Lindgren, F., & Öhman, J. (1998) · Chemometrics and Intelligent Laboratory Systems · doi:10.1016/s0169-7439(98)00109-9 · Cited by 1,089
McGorry, P. D., Yung, A. R., Phillips, L. J., Yuen, H. P., Francey, S., Cosgrave, E. M., Germano, D., Bravin, J., McDonald, T., Blair, A., et al. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.10.921 · Cited by 1,056
Brindle, J. T., Antti, H., Holmes, E., Tranter, G., Nicholson, J. K., Bethell, H. W. L., Clarke, S., Schofield, P. M., McKilligin, E., Mosedale, D. E., et al. (2002) · Nature Medicine · doi:10.1038/nm1202-802 · Cited by 1,029
Self-citationPrabakaran, S., Swatton, J. E., Ryan, M. M., Huffaker, S. J., Huang, J.-J., Griffin, J. L., Wayland, M., Freeman, T., Dudbridge, F., Lilley, K. S., et al. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001511 · Cited by 971
Self-citationImpaired Fasting Glucose Tolerance in First-Episode, Drug-Naive Patients With Schizophrenia
Ryan, M. C. M., Collins, P., & Thakore, J. H. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.2.284 · Cited by 828
Monocarboxylate transporters in the central nervous system: distribution, regulation and function
Pierre, K., & Pellerin, L. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03168.x · Cited by 744
Mathur, R. (2004) · Drug Screening Methods · doi:10.5005/jp/books/10243_6 · Cited by 665
McGlashan, T. H., Zipursky, R. B., Perkins, D., Addington, J., Miller, T., Woods, S. W., A. Hawkins, K., E. Hoffman, R., Preda, A., Epstein, I., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.5.790 · Cited by 556 · cited 1×
“], the Prevention through Risk Identification, Management and Education (PRIME) study [”
BackgroundSchizophrenia: glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo
Do, K. Q., Trabesinger, A. H., Kirsten‐Krüger, M., Lauer, C. J., Dydak, U., Hell, D., Holsboer, F., Boesiger, P., & Cuénod, M. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00229.x · Cited by 540 · cited 1×
“Although a wealth of disease studies have been performed on biofluids such as urine and plasma, relatively few metabolite profiling studies have been performed on CSF for the purpose of disease diagnosis [14–19].”
BackgroundIwamoto, K., Bundo, M., & Kato, T. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi022 · Cited by 495
The challenges of modeling mammalian biocomplexity
Nicholson, J. K., Holmes, E., Lindon, J. C., & Wilson, I. D. (2004) · Nature Biotechnology · doi:10.1038/nbt1015 · Cited by 356
Self-citationCheng, L. L., Ma, M. J., Becerra, L., Ptak, T., Tracey, I., Lackner, A., & González, R. G. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.12.6408 · Cited by 339
Henderson, D. C., Cagliero, E., Copeland, P. M., Borba, C. P., Evins, A. E., Hayden, D., Weber, M. T., Anderson, E. J., Allison, D. B., Daley, T. B., et al. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.1.19 · Cited by 319
LACTATE AS ENERGY SOURCE FOR BRAIN IN GLUCOSE-6-PHOSPHATASE DEFICIENT CHILD
Fernandes, J., Berger, R., & Smit, G. P. A. (1982) · The Lancet · doi:10.1016/s0140-6736(82)90257-4 · Cited by 319
Detection of epithelial ovarian cancer using 1H‐NMR‐based metabonomics
Odunsi, K., Wollman, R. M., Ambrosone, C. B., Hutson, A., McCann, S. E., Tammela, J., Geisler, J. P., Miller, G., Sellers, T., Cliby, W., et al. (2005) · International Journal of Cancer · doi:10.1002/ijc.20651 · Cited by 317
Chakraborty, G., Mekala, P., Yahya, D., Wu, G., & Ledeen, R. W. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00456.x · Cited by 302
Beckwith-Hall, B. M., Nicholson, J. K., Nicholls, A. W., Foxall, P. J. D., Lindon, J. C., Connor, S. C., Abdi, M., Connelly, J., & Holmes, E. (1998) · Chemical Research in Toxicology · doi:10.1021/tx9700679 · Cited by 270
Self-citationSteen, R. G., Hamer, R. M., & Lieberman, J. A. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300850 · Cited by 254
Madhavarao, C. N., Arun, P., Moffett, J. R., Szucs, S., Surendran, S., Matalon, R., Garbern, J., Hristova, D., Johnson, A., Jiang, W., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409184102 · Cited by 212
Mitochondrial complex i subunits expression is altered in schizophrenia: a postmortem study
Karry, R., Klein, E., & Ben Shachar, D. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.12.012 · Cited by 208
Brindle, J. T., Nicholson, J. K., Schofield, P. M., Grainger, D. J., & Holmes, E. (2003) · The Analyst · doi:10.1039/b209155k · Cited by 191
Self-citationArranz, B., Rosel, P., Ramírez, N., Dueñas, R., Fernández, P., Sanchez, J. M., Navarro, M. A., & San, L. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n1007 · Cited by 161
Holmes, E., Foxall, P. J. D., Spraul, M., Duncan Farrant, R., Nicholson, J. K., & Lindon, J. C. (1997) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/s0731-7085(97)00066-6 · Cited by 160
Self-citationMallinckrodt, C. H., Watkin, J. G., Liu, C., Wohlreich, M. M., & Raskin, J. (2005) · BMC Psychiatry · doi:10.1186/1471-244x-5-1 · Cited by 134
Abnormalities of glucose metabolism associated with atypical antipsychotic drugs.
Newcomer, J. W. (2004) · PubMed · Cited by 132
Tsang, T. M., Woodman, B., McLoughlin, G., Griffin, J. L., Tabrizi, S. J., Bates, G. P., & Holmes, E. C. (2006) · Journal of Proteome Research · doi:10.1021/pr050244o · Cited by 129
Self-citationRegional ketone body utilization by rat brain in starvation and diabetes
Hawkins, R. A., Mans, A. M., & Davis, D. W. (1986) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1986.250.2.e169 · Cited by 128
Hashimoto, K., Engberg, G., Shimizu, E., Nordin, C., Lindström, L., & Iyo, M. (2005) · BMC Psychiatry · doi:10.1186/1471-244x-5-6 · Cited by 118
Cheng, L. L., Newell, K., Mallory, A. E., Hyman, B. T., & Gonzalez, R. G. (2002) · Magnetic Resonance Imaging · doi:10.1016/s0730-725x(02)00512-x · Cited by 77 · cited 1×
“Successful application of this technology has achieved identification of biomarkers for a wide range of pathologies, including inborn errors of metabolism, liver and kidney disease, cardiovascular disease, insulin resistance, and neurodegenerative disorders, amongst others [3,4,10–13].”
BackgroundTsang, T. M., Griffin, J. L., Haselden, J. N., Fish, C., & Holmes, E. C. (2005) · Magnetic Resonance in Medicine · doi:10.1002/mrm.20447 · Cited by 67
Self-citationDunne, V. G., Bhattachayya, S., Besser, M., Rae, C. D., & Griffin, J. L. (2004) · NMR in Biomedicine · doi:10.1002/nbm.918 · Cited by 65
1H magnetic resonance spectroscopy in human hydrocephalus
Braun, K. P. J., Gooskens, R. H. J. M., Vandertop, W. P., Tulleken, C. A. F., & van der Grond, J. (2003) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.10270 · Cited by 40
Henderson, D. C., & Ettinger, E. R. (2002) · International review of neurobiology · doi:10.1016/s0074-7742(02)51014-x · Cited by 36
High-resolution 1H NMR spectroscopy of cerebrospinal fluid in spinal diseases
Koschorek, F., Offermann, W., Stelten, J., Braunsdorf, W. E. K., Steller, U., Gremmel, H., & Leibfritz, D. (1993) · Neurosurgical Review · doi:10.1007/bf00383842 · Cited by 31
Gårseth, M., Sonnewald, U., White, L. R., Rød, M., Nygaard, O. P., & Zwart, J. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10357 · Cited by 19
Elman, I., Rott, D., Green, A. I., Langleben, D. D., Lukas, S. E., Goldstein, D. S., & Breier, A. F. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1890-y · Cited by 14
Metabolism of glucose and acetate by the ovine brain in vivo
Kammula, R. G., & Bc, F. (1973) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1973.225.1.110 · Cited by 9
Understanding schizophrenia and diabetes
Dinan, T., Peveler, R., & Holt, R. I. G. (2004) · Hospital Medicine · doi:10.12968/hosp.2004.65.8.15495 · Cited by 8
Cited by
The Human Serum Metabolome (HUSERMET) Consortium, Dunn, W. B., Broadhurst, D., Begley, P., Zelena, E., Francis-McIntyre, S., Anderson, N., Brown, M., Knowles, J. D., Halsall, A., et al. (2011) · Nature Protocols · doi:10.1038/nprot.2011.335 · Cited by 3,294
Evans, A. M., DeHaven, C. D., Barrett, T., Mitchell, M., & Milgram, E. (2009) · Analytical Chemistry · doi:10.1021/ac901536h · Cited by 1,333
Dunn, W. B., Broadhurst, D. I., Atherton, H. J., Goodacre, R., & Griffin, J. L. (2011) · Chem. Soc. Rev. · doi:10.1039/b906712b · Cited by 860
Metabolomics: A Global Biochemical Approach to Drug Response and Disease
Kaddurah-Daouk, R., Kristal, B. S., & Weinshilboum, R. M. (2008) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.48.113006.094715 · Cited by 670
Munger, J., Bennett, B. D., Parikh, A., Feng, X.-J., McArdle, J., Rabitz, H. A., Shenk, T., & Rabinowitz, J. D. (2008) · Nature Biotechnology · doi:10.1038/nbt.1500 · Cited by 635
Metadata
- Authors
- Holmes, E., Tsang, T. M., Huang, J. T.-J., Leweke, F. M., Koethe, D., Gerth, C. W., Nolden, B. M., Gross, S., Schreiber, D., Nicholson, J. K., & Bahn, S.
- Venue
- PLoS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2006-08-22
- Volume
- 3
- Issue
- 8
- Pages
- e327
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- OpenAlex
- W2057251357
- Cited by
- 290
- References
- 41
- FWCI
- 15.52
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.